pillbase.ru

Palsonify

Active substance: paltusotine

paltusotine hydrochloride

Centralised EU authorisationActive

Marketing holder: Crinetics Pharmaceuticals Europe GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • PALSONIFY
    TABLET, FILM COATED · PALTUSOTINE HYDROCHLORIDE 20 mg/1
    84015-920
    Crinetics Pharmaceuticals, Inc.
  • PALSONIFY
    TABLET, FILM COATED · PALTUSOTINE HYDROCHLORIDE 30 mg/1
    84015-930
    Crinetics Pharmaceuticals, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12097-9bc6-7b5f-9f41-be15e835fae9,01a12097-9bcd-79da-b90e-6c4170f4c3bd;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006636
Registration status
Active
ATC code
H01CB06
Sources
  • product · EMA · EMEA/H/C/006636 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006636 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006636 · Verified 2026-10-09